Ravindran Rajisha
Ravindran Rajisha has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Prasanna Kumar Patil
ICAR‐Central Institute of Brackishwater Aquaculture Chennai India
4 shared publications - Satyen Kumar Panda
QA Advisor, Food Safety Standards Authority of India (FSSAI), FDA Bhawan , Kotla Road near Bal Bhawan , New Delhi 110002
3 shared publications - Niladri Sekhar Chatterjee
National Reference Laboratory, ICAR-Central Institute of Fisheries Technology, Matsyapuri P.O., W. Island, Cochin 682029, India
2 shared publications - Ranjit Kumar Nadella
MFB Division, ICAR-Central Institute of Fisheries Technology, Willingdon Island
2 shared publications - A Abhiram
Quality Assurance and Management Division,ICAR-Central Institute of Fisheries Technology (ICAR-CIFT) Willingdon Island, Matsyapuri P.O., Cochin 682029, Kerala
1 shared publication - Ambarish Purackattu Gop
Vizhinjam Regional Centre of ICAR-Central Marine Fisheries Research Institute, Thiruvananthapuram, India
1 shared publication
Latest Publications
- 18 May 2026
- Published by Oxford University Press (OUP) in Journal of AOAC INTERNATIONAL
- Vol. 109 (6) , 966-973
Effect of different processing methods on the reduction of oxytetracycline residues in tilapia ( Oreochromis niloticus )
Background: Oxytetracycline (OTC) is used as a therapeutic agent against bacterial pathogens in aquaculture, typically administered via medicated feed. Insufficient withdrawal time following drug treatment will result in antibiotic residue deposition in the tissues. Antibiotic residues are determined from freshly harvested fish tissues or processed fish samples for export purposes, but sufficient data is not available on the effect of different processing methods on the fate of antibiotic residues in fish tissues. Objective: This study is aimed at understanding the effects of various processing/cooking methods on the retention of OTC residues in the edible fillets of OTC-fed tilapia. Methods: Medicated feed was prepared by coating different doses of OTC into commercially available feed pellets and was administered to the fish in all the treatment groups for 10 days. Edible fillet samples were collected for various processing techniques, including boiling, microwave cooking, frying, and drying. The processed samples were analyzed for OTC residues using liquid chromatography–tandem mass spectrometry (LC–MS/MS). Results: An LOD of 1.75 µg/kg and LOQ of 5.82 µg/kg were achieved by the developed LC–MS/MS method for the quantification of OTC in fish samples. The results revealed a significant reduction of OTC in fish tissues following various processing methods. The maximum degradation was observed by microwave processing and frying. Conclusion: This study provides insights into the effectiveness of various cooking/processing methods for the efficient reduction of OTC residues in edible fish fillets. Highlights: The present study highlights the effects of different processing methods and demonstrates that even when some levels of drug residues are present in fish tissues, they can be effectively degraded using appropriate processing methods.
- 18 May 2026
- Published by Oxford University Press (OUP) in Journal of AOAC INTERNATIONAL
- Vol. 109 (6) , 966-973
Effect of different processing methods on the reduction of oxytetracycline residues in tilapia ( Oreochromis niloticus )
Background: Oxytetracycline (OTC) is used as a therapeutic agent against bacterial pathogens in aquaculture, typically administered via medicated feed. Insufficient withdrawal time following drug treatment will result in antibiotic residue deposition in the tissues. Antibiotic residues are determined from freshly harvested fish tissues or processed fish samples for export purposes, but sufficient data is not available on the effect of different processing methods on the fate of antibiotic residues in fish tissues. Objective: This study is aimed at understanding the effects of various processing/cooking methods on the retention of OTC residues in the edible fillets of OTC-fed tilapia. Methods: Medicated feed was prepared by coating different doses of OTC into commercially available feed pellets and was administered to the fish in all the treatment groups for 10 days. Edible fillet samples were collected for various processing techniques, including boiling, microwave cooking, frying, and drying. The processed samples were analyzed for OTC residues using liquid chromatography–tandem mass spectrometry (LC–MS/MS). Results: An LOD of 1.75 µg/kg and LOQ of 5.82 µg/kg were achieved by the developed LC–MS/MS method for the quantification of OTC in fish samples. The results revealed a significant reduction of OTC in fish tissues following various processing methods. The maximum degradation was observed by microwave processing and frying. Conclusion: This study provides insights into the effectiveness of various cooking/processing methods for the efficient reduction of OTC residues in edible fish fillets. Highlights: The present study highlights the effects of different processing methods and demonstrates that even when some levels of drug residues are present in fish tissues, they can be effectively degraded using appropriate processing methods.
- 24 April 2025
- Published by Oxford University Press (OUP) in Journal of AOAC INTERNATIONAL
- Vol. 108 (5) , 661-669
Evaluating the Lethal Dose (LD50) of Ivermectin for Common Carp: Insights From an Oral Toxicity Study
Background: Ivermectin (IVM) is commonly used for the treatment of parasitic diseases in aquaculture and is administered either through oral or immersion methods, but it lacks regulatory approval. Objective: The aim of the present study was to determine the acute oral toxicity of IVM by estimating the 96 h median lethal dose (LD50) using mortality as endpoint, for an economically important freshwater fish, Cyprinus carpio. Methods: Medicated feed was prepared by employing different doses of IVM top-dressed onto the commercial feed pellets. A single oral dose of IVM at different doses (mg/kg b.wt.) of 0 (control-T1), 1 (T2), 2.5 (T3), 5 (T4), 10 (T5), 12 (T6), 15 (T7), 18 (T8), 21 (T9), 25 (T10), and 50 (T11) was dissolved in dimethyl sulfoxide (DMSO) and top-dressed using 0.5% w/v guar gum as a wet binder to the feed. The medicated feed was administered at 3% b.wt. to all treatment groups and cumulative mortalities were recorded over a duration of 96 h. Results: The estimated LD50 of IVM was found to be 8.91 ± 3.46 mg/kg·b.wt. Furthermore, the treatment group (T2) was administered a single oral dose of 1 mg/kg b.wt. and did not exhibit any noticeable behavioral changes compared to the control group. Similarly, LOAEL and NOEAL doses were found to be 2.5 mg/kg b.wt. and 1 mg/kg b.wt., respectively. Conclusions: This study provides valuable insights for further determining the safe dosage of IVM that can be used in aquaculture for the treatment of parasitic diseases. Highlights: The present study might be helpful for fixing the maximum residual limit (MRL) for IVM in the aquaculture sector, and the data will be helpful for prescription of the drug by regulatory authorities for treating parasitic diseases in fish.
- 24 April 2025
- Published by Oxford University Press (OUP) in Journal of AOAC INTERNATIONAL
- Vol. 108 (5) , 661-669
Evaluating the Lethal Dose (LD50) of Ivermectin for Common Carp: Insights From an Oral Toxicity Study
Background: Ivermectin (IVM) is commonly used for the treatment of parasitic diseases in aquaculture and is administered either through oral or immersion methods, but it lacks regulatory approval. Objective: The aim of the present study was to determine the acute oral toxicity of IVM by estimating the 96 h median lethal dose (LD50) using mortality as endpoint, for an economically important freshwater fish, Cyprinus carpio. Methods: Medicated feed was prepared by employing different doses of IVM top-dressed onto the commercial feed pellets. A single oral dose of IVM at different doses (mg/kg b.wt.) of 0 (control-T1), 1 (T2), 2.5 (T3), 5 (T4), 10 (T5), 12 (T6), 15 (T7), 18 (T8), 21 (T9), 25 (T10), and 50 (T11) was dissolved in dimethyl sulfoxide (DMSO) and top-dressed using 0.5% w/v guar gum as a wet binder to the feed. The medicated feed was administered at 3% b.wt. to all treatment groups and cumulative mortalities were recorded over a duration of 96 h. Results: The estimated LD50 of IVM was found to be 8.91 ± 3.46 mg/kg·b.wt. Furthermore, the treatment group (T2) was administered a single oral dose of 1 mg/kg b.wt. and did not exhibit any noticeable behavioral changes compared to the control group. Similarly, LOAEL and NOEAL doses were found to be 2.5 mg/kg b.wt. and 1 mg/kg b.wt., respectively. Conclusions: This study provides valuable insights for further determining the safe dosage of IVM that can be used in aquaculture for the treatment of parasitic diseases. Highlights: The present study might be helpful for fixing the maximum residual limit (MRL) for IVM in the aquaculture sector, and the data will be helpful for prescription of the drug by regulatory authorities for treating parasitic diseases in fish.
- Open Access
- 22 January 2024
- Published by Elsevier in Emerging Animal Species
- Vol. 10
In-feed antiparasitic veterinary drug emamectin benzoate impairs acetylcholinesterase activity and brain tissue histoarchitecture of Oreochromis niloticus fry
- 22 January 2024
- Published by Elsevier in Emerging Animal Species
- Vol. 10
Open AccessIn-feed antiparasitic veterinary drug emamectin benzoate impairs acetylcholinesterase activity and brain tissue histoarchitecture of Oreochromis niloticus fry
- 23 March 2023
- Published by Springer Nature in Fish Physiology and Biochemistry
- Vol. 49 (2) , 307-320
Pharmacokinetics and tissue distribution of florfenicol and florfenicol amine in snubnose pompano (Trachinotus blochii) following oral administration
The present study reports the comparative pharmacokinetic profiles of florfenicol and its metabolite (florfenicol amine, FFA) in Trachinotus blochii under tropical marine conditions (salinity: 35 ± 1.4‰; temperature: 28.8 ± 0.54 °C) following a single in-feed oral administration of the recommended dose (15 mg/Kg). Furthermore, the study investigated the distribution of these two compounds in nine different tissues. The maximum florfenicol concentrations (Cmax) in plasma and tissues were observed within five hours (Tmax), except for bile. The Cmax ranged from 572 to 1954 ng/g or ml and was in the intestine > bile > muscle + skin > liver > gill = heart > plasma > kidney = spleen. The elimination half-life of FFC was significantly slower in the bile (38.25 ± 4.46 h). The AUC tissue/plasma was highest for bile (3.77 ± 0.22), followed by intestine > muscle + skin > heart > liver > kidney = gill = spleen. Tmax and t1/2β were slower, and Cmax was lower for FFA than florfenicol in all tissues except Cmax of the kidney and bile. FFA t1/2β was exceptionally slower in the kidney (46.01 ± 8.2 h). Interestingly, reaching an apparent distribution rate of > 0.5 was comparatively faster in the kidney, liver, and gills than in other tissues. The highest apparent metabolic rate was in the kidney (0.95 ± 0.01) and the lowest in plasma (0.41 ± 0.01). The generated data can be applied for formulating efficient therapeutic protocols in T. blochii, a promising mariculture species. Graphical Abstract
- 23 March 2023
- Published by Springer Nature in Fish Physiology and Biochemistry
- Vol. 49 (2) , 307-320
Pharmacokinetics and tissue distribution of florfenicol and florfenicol amine in snubnose pompano (Trachinotus blochii) following oral administration
The present study reports the comparative pharmacokinetic profiles of florfenicol and its metabolite (florfenicol amine, FFA) in Trachinotus blochii under tropical marine conditions (salinity: 35 ± 1.4‰; temperature: 28.8 ± 0.54 °C) following a single in-feed oral administration of the recommended dose (15 mg/Kg). Furthermore, the study investigated the distribution of these two compounds in nine different tissues. The maximum florfenicol concentrations (Cmax) in plasma and tissues were observed within five hours (Tmax), except for bile. The Cmax ranged from 572 to 1954 ng/g or ml and was in the intestine > bile > muscle + skin > liver > gill = heart > plasma > kidney = spleen. The elimination half-life of FFC was significantly slower in the bile (38.25 ± 4.46 h). The AUC tissue/plasma was highest for bile (3.77 ± 0.22), followed by intestine > muscle + skin > heart > liver > kidney = gill = spleen. Tmax and t1/2β were slower, and Cmax was lower for FFA than florfenicol in all tissues except Cmax of the kidney and bile. FFA t1/2β was exceptionally slower in the kidney (46.01 ± 8.2 h). Interestingly, reaching an apparent distribution rate of > 0.5 was comparatively faster in the kidney, liver, and gills than in other tissues. The highest apparent metabolic rate was in the kidney (0.95 ± 0.01) and the lowest in plasma (0.41 ± 0.01). The generated data can be applied for formulating efficient therapeutic protocols in T. blochii, a promising mariculture species. Graphical Abstract
- Open Access
- 3 January 2023
- Published by MDPI AG in Veterinary Sciences
- Vol. 10 (1) , 36
Impacts of Oral Florfenicol Medication and Residues on the Kidney and Liver of Nile Tilapia Oreochromis niloticus (L.)
Florfenicol (FFC), an approved aquaculture antibiotic, is administered in feed at doses of 10–15 mg kg biomass−1 day−1 for 10 successive days. In this study, healthy Oreochromis niloticus were fed with 0–10 times the therapeutic dose of 15 mg kg biomass−1 day−1 for 10 days and tracked for 43 days post dosing. Assessments of residue accrual and depletion, oxidative stress, serum biochemistry, histopathology and extent of kidney and liver damages were made. FFC dosing reduced the feed intake significantly. The therapeutic dose produced no mortalities on day 10. Dose-dependent alterations in serum biochemistry were noted upon dosing. Several histopathological alterations were observed in the kidney and liver, which vindicated the toxic potentials of FFC. The residual FFC and florfenicol amine (FFA) accrual, depletion and oxidative stress responses, such as increased malondialdehyde, total nitric oxide, ferric reducing antioxidant power and reduced glutathione S-transferase activity, were documented. The dietary FFC persuaded the physiological state of O. niloticus, the effects of which normalized sparsely with time upon cessation of dosing at the higher doses. The study provided a brief outlook on the physiological responses upon oral FFC administration, which should be kept in mind during its application for fish health safety purposes.
- 3 January 2023
- Published by MDPI AG in Veterinary Sciences
- Vol. 10 (1) , 36
Open AccessImpacts of Oral Florfenicol Medication and Residues on the Kidney and Liver of Nile Tilapia Oreochromis niloticus (L.)
Florfenicol (FFC), an approved aquaculture antibiotic, is administered in feed at doses of 10–15 mg kg biomass−1 day−1 for 10 successive days. In this study, healthy Oreochromis niloticus were fed with 0–10 times the therapeutic dose of 15 mg kg biomass−1 day−1 for 10 days and tracked for 43 days post dosing. Assessments of residue accrual and depletion, oxidative stress, serum biochemistry, histopathology and extent of kidney and liver damages were made. FFC dosing reduced the feed intake significantly. The therapeutic dose produced no mortalities on day 10. Dose-dependent alterations in serum biochemistry were noted upon dosing. Several histopathological alterations were observed in the kidney and liver, which vindicated the toxic potentials of FFC. The residual FFC and florfenicol amine (FFA) accrual, depletion and oxidative stress responses, such as increased malondialdehyde, total nitric oxide, ferric reducing antioxidant power and reduced glutathione S-transferase activity, were documented. The dietary FFC persuaded the physiological state of O. niloticus, the effects of which normalized sparsely with time upon cessation of dosing at the higher doses. The study provided a brief outlook on the physiological responses upon oral FFC administration, which should be kept in mind during its application for fish health safety purposes.